Clinical trials
Carcinoma, Non-Small-Cell Lung trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
795 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 6 |
| 2003 | 6 |
| 2004 | 11 |
| 2005 | 13 |
| 2006 | 18 |
| 2007 | 19 |
| 2008 | 26 |
| 2009 | 20 |
| 2010 | 17 |
| 2011 | 16 |
| 2012 | 25 |
| 2013 | 26 |
| 2014 | 18 |
| 2015 | 46 |
| 2016 | 38 |
| 2017 | 36 |
| 2018 | 36 |
| 2019 | 53 |
| 2020 | 47 |
| 2021 | 62 |
| 2022 | 56 |
| 2023 | 44 |
| 2024 | 58 |
| 2025 | 54 |
| 2026 | 25 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 341 |
| Active, not recruiting | 141 |
| Recruiting | 137 |
| Terminated | 122 |
| Unknown status | 31 |
| Not yet recruiting | 11 |
| Withdrawn | 9 |
| Available | 2 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 53 |
| Eli Lilly and Company | 46 |
| Novartis Pharmaceuticals | 43 |
| Hoffmann-La Roche | 39 |
| Bristol-Myers Squibb | 36 |
| Intergroupe Francophone de Cancerologie Thoracique | 32 |
| Merck Sharp & Dohme LLC | 25 |
| Pfizer | 23 |
| GlaxoSmithKline | 18 |
| AbbVie | 15 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 795 |
| Lung Neoplasms | 156 |
| Neoplasms | 82 |
| Neoplasm Metastasis | 67 |
| Colorectal Neoplasms | 61 |
| Melanoma | 53 |
| Triple Negative Breast Neoplasms | 37 |
| Breast Neoplasms | 34 |
| Squamous Cell Carcinoma of Head and Neck | 31 |
| Ovarian Neoplasms | 30 |
Trials
Showing 1 to 25 of 795. Each trial links to its page on Pharma Observatory.
695 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.